"Antigens, Protozoan" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered.
| Descriptor ID |
D000953
|
| MeSH Number(s) |
D23.050.293
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antigens, Protozoan".
Below are MeSH descriptors whose meaning is more specific than "Antigens, Protozoan".
This graph shows the total number of publications written about "Antigens, Protozoan" by people in this website by year, and whether "Antigens, Protozoan" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 4 | 7 |
| 1997 | 3 | 4 | 7 |
| 1998 | 8 | 1 | 9 |
| 1999 | 6 | 0 | 6 |
| 2000 | 3 | 3 | 6 |
| 2001 | 5 | 3 | 8 |
| 2002 | 4 | 1 | 5 |
| 2003 | 3 | 3 | 6 |
| 2004 | 3 | 1 | 4 |
| 2005 | 5 | 1 | 6 |
| 2006 | 6 | 4 | 10 |
| 2007 | 5 | 3 | 8 |
| 2008 | 3 | 1 | 4 |
| 2009 | 3 | 2 | 5 |
| 2010 | 2 | 5 | 7 |
| 2011 | 9 | 9 | 18 |
| 2012 | 8 | 5 | 13 |
| 2013 | 12 | 2 | 14 |
| 2014 | 7 | 3 | 10 |
| 2015 | 9 | 6 | 15 |
| 2016 | 5 | 5 | 10 |
| 2017 | 8 | 6 | 14 |
| 2018 | 9 | 6 | 15 |
| 2019 | 9 | 3 | 12 |
| 2020 | 6 | 3 | 9 |
| 2021 | 6 | 6 | 12 |
| 2022 | 0 | 6 | 6 |
| 2023 | 0 | 7 | 7 |
| 2024 | 6 | 3 | 9 |
| 2025 | 6 | 0 | 6 |
Below are the most recent publications written about "Antigens, Protozoan" by people in Profiles.
-
Surface antigen SAG1 mediates Toxoplasma gondii fitness and host cell attachment in IFNγ-stimulated cells. Infect Immun. 2025 Aug 12; 93(8):e0001025.
-
Field evaluation of the Bioline Malaria Ag P.f/Pan rapid diagnostic test: causes of microscopy discordance and performance in Uganda. Malar J. 2025 May 01; 24(1):138.
-
Estimating malaria antigen dynamics and the time to negativity of next-generation malaria rapid diagnostic tests. Malar J. 2025 Apr 04; 24(1):109.
-
Design and development of highly conserved, HLA-promiscuous T cell multiepitope vaccines against human visceral leishmaniasis. Front Immunol. 2025; 16:1540537.
-
Liver stage P. falciparum antigens highly targeted by CD4+ T cells in malaria-exposed Ugandan children. PLoS Pathog. 2025 Feb; 21(2):e1012943.
-
Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes. PLoS One. 2025; 20(2):e0318098.
-
Molecular surveillance of Plasmodium falciparum histidine-rich protein 2/3 gene deletions in Mozambique, 2023. Malar J. 2024 Dec 26; 23(1):402.
-
Post-treatment duration of positivity for standard and ultra-sensitive Plasmodium falciparum antigen-based rapid diagnostic tests, a cohort study from a low-endemic setting in Namibia. EBioMedicine. 2025 Jan; 111:105489.
-
Plasmodium falciparum molecular surveillance to inform the Mozambican National Malaria Control Programme strategy: protocol. BMJ Open. 2024 Nov 24; 14(11):e092590.
-
Differences in phenotype between long-lived memory B cells against Plasmodium falciparum merozoite antigens and variant surface antigens. PLoS Pathog. 2024 Oct; 20(10):e1012661.